Text of US HB 7183 (2024)

I 118TH CONGRESS 2D SESSION H. R. 7183 To prohibit Federal funds from being used to provide certain gender transition procedures to minors. IN THE HOUSE OF REPRESENTATIVES FEBRUARY 1, 2024 Mr. MCCORMICK (for himself, Mr. ALFORD, Mr. ALLEN, Mr. ARRINGTON, Mr. BIGGS, Ms. BOEBERT, Mr. BURLISON, Mr. CLINE, Mr. CLYDE, Mr. COL- LINS, Mr. DUNCAN, Mr. SCOTT FRANKLIN of Florida, Mr. MIKE GARCIA of California, Mr. TONY GONZALES of Texas, Mr. GOODEN of Texas, Mr. GROTHMAN, Mr. HARRIS, Mrs. HARSHBARGER, Mr. JACKSON of Texas, Mr. KELLY of Mississippi, Mr. LAMBORN, Mrs. LUNA, Mrs. MILLER of Illinois, Mrs. MILLER of West Virginia, Mr. MOONEY, Mr. MOORE of Ala- bama, Mr. MURPHY, Mr. NEHLS, Mr. NORMAN, Mr. OGLES, Mr. POSEY, Mr. ROUZER, Mr. AUSTIN SCOTT of Georgia, Mr. STEUBE, Ms. TENNEY, Mr. TIFFANY, Mr. TIMMONS, Mr. VAN DREW, Ms. VAN DUYNE, Mr. WEBER of Texas, Mr. BABIN, Mrs. LESKO, Mr. WILLIAMS of Texas, Mr. LOUDERMILK, and Mr. WESTERMAN) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To prohibit Federal funds from being used to provide certain gender transition procedures to minors. Be it enacted by the Senate and House of Representa- 1 tives of the United States of America in Congress assembled, 2 VerDate Sep 11 2014 20:57 Feb 06, 2024 Jkt 049200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\H7183.IH H7183 ssavage on LAPJG3WLY3PROD with BILLS 2 •HR 7183 IH SECTION 1. SHORT TITLE. 1 This Act may be cited as the ‘‘Protecting Resources 2 Of Taxpayers to Eliminate Childhood Transgender Sur- 3 geries Act of 2024’’ or the ‘‘PROTECTS Act of 2024’’. 4 SEC. 2. PROHIBITING FEDERAL FUNDS FROM BEING USED 5 TO PROVIDE CERTAIN GENDER TRANSITION 6 PROCEDURES TO MINORS. 7 (a) IN GENERAL.—Notwithstanding any other provi- 8 sion of law, no Federal funds may be used or otherwise 9 made available to provide or refer for a specified gender 10 transition procedure to an individual under the age of 18 11 or to reimburse any entity for providing such a procedure 12 to such an individual. 13 (b) SPECIFIED GENDER TRANSITION PROCEDURE 14 DEFINED.— 15 (1) IN GENERAL.—For purposes of this para- 16 graph, except as provided in paragraph (2), the term 17 ‘‘specified gender transition procedure’’ means, with 18 respect to an individual, any of the following when 19 performed for the purpose of intentionally changing 20 the body of such individual to no longer correspond 21 to their sex: 22 (A) Performing any surgery, including— 23 (i) castration; 24 (ii) orchiectomy; 25 (iii) scrotoplasty; 26 VerDate Sep 11 2014 20:57 Feb 06, 2024 Jkt 049200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\H7183.IH H7183 ssavage on LAPJG3WLY3PROD with BILLS 3 •HR 7183 IH (iv) vasectomy; 1 (v) hysterectomy; 2 (vi) oophorectomy; 3 (vii) ovariectomy; 4 (viii) metoidioplasty; 5 (ix) penectomy; 6 (x) phalloplasty; 7 (xi) vaginoplasty; 8 (xii) vaginectomy; 9 (xiii) vulvoplasty; 10 (xiv) reduction thyrochondroplasty; 11 (xv) chondrolaryngoplasty; 12 (xvi) mastectomy; and 13 (xvii) any plastic, cosmetic, or aes- 14 thetic surgery that feminizes or 15 masculinizes the facial or other body fea- 16 tures of an individual. 17 (B) Any placement of chest implants to 18 create feminine breasts. 19 (C) Any placement of fat or artificial im- 20 plants in the gluteal region. 21 (D) Administering, supplying, prescribing, 22 dispensing, distributing, or otherwise conveying 23 to an individual medications, including— 24 VerDate Sep 11 2014 20:57 Feb 06, 2024 Jkt 049200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6201 E:\BILLS\H7183.IH H7183 ssavage on LAPJG3WLY3PROD with BILLS 4 •HR 7183 IH (i) gonadotropin-releasing hormone 1 (GnRH) analogues or other puberty-block- 2 ing drugs to stop or delay normal puberty; 3 and 4 (ii) testosterone, estrogen, or other 5 androgens to an individual at doses that 6 are supraphysiologic than would normally 7 be produced endogenously in a healthy in- 8 dividual of the same age and sex. 9 (2) EXCEPTION.—Paragraph (1) shall not 10 apply to the following when furnished to an indi- 11 vidual by a health care provider with the consent of 12 such individual’s parent or legal guardian: 13 (A) Puberty suppression or blocking pre- 14 scription drugs for the purpose of normalizing 15 puberty for an individual experiencing pre- 16 cocious puberty. 17 (B) Appropriate and medically necessary 18 procedures or treatments to correct for— 19 (i) a medically verifiable genetic dis- 20 order of sex development, including— 21 (I) 46,XX chromosomes with 22 virilization; 23 (II) 46,XY chromosomes with 24 undervirilization; and 25 VerDate Sep 11 2014 20:57 Feb 06, 2024 Jkt 049200 PO 00000 Frm 00004 Fmt 6652 Sfmt 6201 E:\BILLS\H7183.IH H7183 ssavage on LAPJG3WLY3PROD with BILLS 5 •HR 7183 IH (III) both ovarian and testicular 1 tissue; 2 (ii) sex chromosome structure, sex 3 steroid hormone production, or sex hor- 4 mone action, if determined to be abnormal 5 by a physician through genetic or bio- 6 chemical testing; or 7 (iii) infection, disease, injury, or dis- 8 order caused or exacerbated by a previous 9 procedure described in paragraph (1), or a 10 physical disorder, physical injury, or phys- 11 ical illness that would, as certified by a 12 physician, place the individual in imminent 13 danger of death or impairment of a major 14 bodily function unless the procedure is per- 15 formed, not including procedures per- 16 formed for the alleviation of mental dis- 17 tress. 18 (3) SEX.—For purposes of paragraph (1), the 19 term ‘‘sex’’ means the indication of male or female 20 sex by reproductive potential or capacity, sex chro- 21 mosomes, naturally occurring sex hormones, gonads, 22 or internal or external genitalia present at birth. 23 Æ VerDate Sep 11 2014 20:57 Feb 06, 2024 Jkt 049200 PO 00000 Frm 00005 Fmt 6652 Sfmt 6301 E:\BILLS\H7183.IH H7183 ssavage on LAPJG3WLY3PROD with BILLS